First-in-human in vivo non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinoma
Intratumoral genetic heterogeneity and the role of metabolic reprogramming in renal cell carcinoma (RCC) have been extensively documented. However, the distribution of these metabolic changes within the tissue has not been explored. We report on the first-in-human non-invasive metabolic interrogatio...
Saved in:
Published in | BJR case reports Vol. 5; no. 3; p. 20190003 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
The British Institute of Radiology
02.05.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Intratumoral genetic heterogeneity and the role of metabolic reprogramming in renal cell carcinoma (RCC) have been extensively documented. However, the distribution of these metabolic changes within the tissue has not been explored. We report on the first-in-human
non-invasive metabolic interrogation of RCC using hyperpolarized carbon-13 (
C) magnetic resonance imaging (HP-MRI) and describe the validation of
lactate metabolic heterogeneity against multi-regional
mass spectrometry. HP-MRI provides an
assessment of metabolism and provides a novel opportunity to safely and non-invasively assess cancer heterogeneity. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2055-7159 2055-7159 |
DOI: | 10.1259/bjrcr.20190003 |